Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, the stabilization has another week to week and a half to go. I bet and have previously predicted that, at 9:29 am ET on 2/12, it will be closer to .07 than it will be to .17 If it's closer to .17, you win and I'm gone.
Here's a perfect example from the summer of '16:
6/27/16: .22
7/25/16: .60
8/22/16: .27
and it's been all downhill since, except for the .16 to .30 to .11 pump and dump from March 2017
stable???? The pump and dump just ended. It lasted 3-4 weeks. Give it the same timeframe to settle back. You'll see, and you know you will.
Because I loathe penny stock pump and dump schemes. This company's chart is a visual parade of them over the years and shows how they turn out. You'll see and you know it. How many O/S do you think there are now Taylor? That's the $64,000 question.
Taylor, I am not wrong about the accreditation affecting the rating. I am very familiar with BBB ratings, as I sell for a company that is not accredited but has an A+ rating. The accreditation comes with joining the BBB(paying them) and being able to use their logo in your company's advertising. You are wrong.
I hope all enjoyed the little run that appears to have lost its steam, as the "promotion" (AKA pump & dump) that fueled it is evidently over. Barring an announcement of the original ANDA's approval, I predict it'll be back to pre-promo levels as there are 2 months before the 10K and then May 15 when management is forced to show their O/S cards after the January "promo." Yeah, it didn't hit .05-.06 EOY like I thought it might. At the same time, it certainly didn't blow past .20 to .25 either like many predicted as the "promo" unfolded. The next 4 months are all that matter now.
BBB isn't irrelevant to anyone who is in business.... And their ratings have nothing to do with accreditation. The BBB asked for simple proof of their product claims which, naturally, there are none for snake oils. If they only had kept their eyes on the Fluti ball going back to 2014, they could have grabbed the old prescription user base and been and an early innovator in the OTC sphere. They'd would have profitable by 2016. But that ship sailed and now they're just another "me too" company in a saturated landscape of Flonase knock-offs.
A good portion of the Amazon ratings you cite were a flurry of bogus FlutiCare testimonials by shareholders that were being posted before they were even shipping the product during the launch. I called that out already as it was happening. Like I said, it's hard to get an F rating with the BBB if you put any effort into addressing their questions.
and they don't give "F's" out without reason. It's relatively easy to maintain an "A" or "A+" BBB rating if you conduct your business honestly and with integrity.
https://www.bbb.org/sdoc/business-reviews/pharmaceutical-manufacturing/innovus-pharmaceuticals-inc-in-san-diego-ca-172015526
He has never ruled out a reverse split Cleveland. He reverse split NexMed right before he changed the name to Apricus. So his past actions actually point to him doing one. For all the bulls out there: How many O/S are there now? Is buying shares without an answer to that question wise???
It already has, just like the previous P&D's. This is not a healthy pullback or consolidation or whatever happy face you want to paint on it. Another group of bagholders was just created through an OTC "promotion."
1.29M shares traded in 1st hour and down another 15%. How many more examples of a pump and dump does one need? $1/share Doc? Really? Of course that's all possible with that 15:1 reverse split option
...and besides Shawn, when's a better opportunity to re-invest than when the share price is torpedoing after the latest pump and dump?
Laughing is good therapy after a pump and dump!
Yes, efinitely wait for $1. Just ignore the 10:1 or 15:1 reverse split that will get it there.
"we better get out in front of this." LOL. I've never in my life seen a PR like that before.
Charts do not lie. Did Damaj hire the 3 promo firms , or did they, on their own volition, just decide to promote (pump) INNV stock simotaneously?
Yep, you keep thinking that. Look at the 5 year chart. It's a movie in re-runs
It's like a movie script to a movie you've seen 4 times.
For those in under .10, a nice 2 week profit, as long as you took it.
No, this round's over Cleveland. I challenged it wouldnt hold .15 to Feb 12.
We'll see. Most have seen this all before. 3M volume to 750K in one day pretty much sums it up.
Smart, nice work MCM. Congrats
They only have to put O/S in the 10K as to how they rest on 12/31/17. He's shrewd starting this "promo" after Jan 1. Do you know what the S-4 regulations are on an OTCQB stock? Is there a possibility that we may not know the O/S result of this "promo" until the May 15 10Q??
Yes, on the 18th open. But it did hit .13 that day and .14 on the 19th, so I'd still say there's really no gap to fill.
What gap is that BooDog? Looks like it's already done that. 4M shares traded and unchanged? This party's over by the looks of it.
Exactly Mitch. Three of them going full bore. Looks like .185 was the best they could do with it, as it's bounced back off that twice. I wonder where the O/S are standing right now after this 3-way push between LION, GALX, and PTA and how much longer they run it. So far it looks to be about 24.4M shares in that timeframe.
Look, you just contradicted yourself in your reply. First you say they have contracted an outside call center team of 75 to handle their orders. Then you post management's statement saying that, as of this past November, they are handling order fulfillment in-house. I love the way your arguments constantly change. I asked you the head count for their "entire call center team" that you stated and you replied 75. Now all of the sudden, it's not a dedicated team, but it's a shared team with other products/companies. Which is it anyway?
So they're spending $3 - $3.5M per year to answer the phones?
Entire call center? Hmm, that's fairly ambiguous. A 5 person call center or a 150 person call center? Not only is the $8M a mystery, what about the additional $1.5M per quarter loss on top of the mystery 8 gross profit??
$8M. That's a lot of growing pains! 8 million dollars, 1 office, 6 or so people. And that accountant!
Talk to me on 2/12 like I said. Every spike in share price has not lasted 30 days. If this makes past 30 days, I'll concede I'm wrong about this moving forward. Perfectly reasonable and perfectly logical. Where are those $8M Cleveland?
Crickets. Hmmm. Too many facts to digest? I'll ask again, where are those $8M??
You calling holding management accountable "bashing" is a laugh riot. Like HC aptly stated, generating 80% margins on on-line product sales by a company of 6 or so people should have shown profitability a while ago. Taylor's public company accounting costs as the reason is rather lame. $10M in revs at 80 pts of margin means the costs of goods were $2M. Where did the other $8M go?
Let's say we see where INNV stands at the opening bell on Feb 12. It's never maintained a run for more than 30 days. I will concede if it closes at or above .15
Great point. How come that question never gets asked on these "conference calls?"
Doc: Show me a photo of something INNV markets that's on a brick & mortar store's shelf. Show me one.
That's such an OTC thing to say, Doc. Everything's always "right around the corner" in OTC land. They have to sell the stuff. Kudos to them if they do it and achieve profitability... I will tip my hat to them. But saying the past is 'over and done with?.." not so fast. That's not how the market works. Take AVEO for example. They fired previous management and brought in partners like EUSA, NVS, and CanBridge in 2015. That stock did nothing but continue to slide, even with turnaround, until they proved themselves last June. The proof is what matters. The hype.....well, we've seen what happens here before with just hype.
Careful with the facts, Honey. They are not part of the narrative.
Dr. Needle references presenting Tinivo data at the "upcoming ASCO GU Conference" in the PR on HCC. That conference started Thursday and ends today: https://www.asco.org/2018-gastrointestinal-cancers-symposium
Hmmmmm.
Yeah Honey, the market doesn't care about missing guidance that's already been lowered by 33%. Really Bat?